Human Molecular Genetics Advance Access published online on June 22, 2005
Human Molecular Genetics, doi:10.1093/hmg/ddi221
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 National Cancer Institute, Cancer and Developmental Biology Laboratory, Frederick, MD 21702
* To whom correspondence should be addressed. The nuclear lamina is an approximately 10 nm thick proteinaceous layer underlying the inner nuclear membrane. The A-type lamins, nuclear intermediate filament proteins encoded by the LMNA gene, are basic components of the nuclear lamina. Mutations in LMNA are associated with the laminopathies, congenital diseases affecting tissue regeneration and homeostasis. One of these laminopathies associated with missense mutations in LMNA is dilated cardiomyopathy with conduction system disease (DCM-CD1). To understand how the laminopathies arise from different mutations in a single gene, we derived a mouse line by homologous recombination expressing the Lmna-N195K variant of the A-type lamins with an asparagine-to-lysine substitution at amino acid 195, which causes DCM in humans. This mouse line shows characteristics consistent with dilated cardiomyopathy with conduction system disease (DCM-CD1). Continuous EKG monitoring of cardiac activity demonstrated that LmnaN195K/N195K mice die an early death due to arrhythmia. By immunofluorescence and Western analysis, the transcription factor Hf1b/Sp4, and the gap junction proteins connexin 40 and connexin 43, were mis-expressed and/or mis-localized in LmnaN195K/N195K hearts. Desmin staining revealed a loss of organization at sarcomeres and intercalated disks. Mutations within the LMNA gene may therefore cause cardiomyopathy by disrupting the internal organization of the cardiomyocyte, and/or altering the expression of transcription factors essential to normal cardiac development, aging or function.
Received May 2, 2005
Revised May 24, 2005
Accepted June 16, 2005
Article
Expression of a LMNA-N195K Variant of A-Type Lamins Results in Cardiac Conduction Defects and Death in Mice
2 Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232-6300
3 NCI-Frederick, Cancer and Developmental Biology Laboratory, P.O. Box B, Building 539, Room 121A
Colin L. Stewart, E-mail: stewartc{at}ncifcrf.gov
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. D. McCauley and X. H. T. Wehrens Animal models of arrhythmogenic cardiomyopathy Dis. Model. Mech., November 1, 2009; 2(11-12): 563 - 570. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Puckelwartz, E. Kessler, Y. Zhang, D. Hodzic, K. N. Randles, G. Morris, J. U. Earley, M. Hadhazy, J. M. Holaska, S. K. Mewborn, et al. Disruption of nesprin-1 produces an Emery Dreifuss muscular dystrophy-like phenotype in mice Hum. Mol. Genet., February 15, 2009; 18(4): 607 - 620. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, A. A. Panteleyev, D. M. Owens, K. Djabali, C. L. Stewart, and H. J. Worman Epidermal expression of the truncated prelamin A causing Hutchinson-Gilford progeria syndrome: effects on keratinocytes, hair and skin Hum. Mol. Genet., August 1, 2008; 17(15): 2357 - 2369. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Holaska Emerin and the Nuclear Lamina in Muscle and Cardiac Disease Circ. Res., July 3, 2008; 103(1): 16 - 23. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Muchir, P. Pavlidis, G. Bonne, Y. K. Hayashi, and H. J. Worman Activation of MAPK in hearts of EMD null mice: similarities between mouse models of X-linked and autosomal dominant Emery Dreifuss muscular dystrophy Hum. Mol. Genet., August 1, 2007; 16(15): 1884 - 1895. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Capell, F. S. Collins, and E. G. Nabel Mechanisms of Cardiovascular Disease in Accelerated Aging Syndromes Circ. Res., July 6, 2007; 101(1): 13 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, A. J. Herron, and H. J. Worman Pathology and nuclear abnormalities in hearts of transgenic mice expressing M371K lamin A encoded by an LMNA mutation causing Emery-Dreifuss muscular dystrophy Hum. Mol. Genet., August 15, 2006; 15(16): 2479 - 2489. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. V. Broers, F. C. S. Ramaekers, G. Bonne, R. B. Yaou, and C. J. Hutchison Nuclear lamins: laminopathies and their role in premature ageing. Physiol Rev, July 1, 2006; 86(3): 967 - 1008. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Manju, B. Muralikrishna, and V. K Parnaik Expression of disease-causing lamin A mutants impairs the formation of DNA repair foci J. Cell Sci., July 1, 2006; 119(13): 2704 - 2714. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ozawa, Y. K. Hayashi, M. Ogawa, R. Kurokawa, H. Matsumoto, S. Noguchi, I. Nonaka, and I. Nishino Emerin-Lacking Mice Show Minimal Motor and Cardiac Dysfunctions with Nuclear-Associated Vacuoles Am. J. Pathol., March 1, 2006; 168(3): 907 - 917. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Young, L. G. Fong, and S. Michaelis Thematic Review Series: Lipid Posttranslational Modifications. Prelamin A, Zmpste24, misshapen cell nuclei, and progeria--new evidence suggesting that protein farnesylation could be important for disease pathogenesis J. Lipid Res., December 1, 2005; 46(12): 2531 - 2558. [Abstract] [Full Text] [PDF] |
||||






